Home » Blog » Affordable Care Act: Will it Matter If Coverage Is Affordable If There Are No Insurers to Buy it From?

Affordable Care Act: Will it Matter If Coverage Is Affordable If There Are No Insurers to Buy it From?


IP Blog | Dave Melin | August 22, 2016

This week’s BioBlog focuses on the landscape of the ACA after another insurer pulls out; the increase in Part D spending and; big data in cancer research.

Aetna’s ACA Exchange Exit: the Fallout

“Aetna pulling out is like Lehman Brothers failing during the mortgage crisis. It is the bellwether that highlights the underlying fault line in the Affordable Care Act,” he told FierceHeathPayer in an email.

Obamacare Options? In Many Parts of Country, Only One Insurer Will Remain

According to an analysis done for The Upshot by the McKinsey Center for U.S. Health System Reform, 17 percent of Americans eligible for an Affordable Care Act plan may have only one insurer to choose next year.

Prescription Drug Spending Costs Up Under ACA, Out of Pocket Costs Down

The newly insured filled, on average, 28 percent more prescriptions and had 29 percent less out-of-pocket spending per prescription in 2014 compared to 2013, finds a new study from Health Affairs.

CMS: Part D Spending on Drugs Grew 17% in 2014

CMS Chief Data Officer Niall Brennan said in a statement. “Today’s release joins a series of actions the Administration is taking to improve transparency around government data, including the cost of prescription drugs.”

Can Big Data Launch Cancer Research?

In this editorial piece from Cancer Today, Editor-In-Chief William G. Nelson, MD, PhD shares his thoughts on the impact big data can have on the Cancer Moonshot initiative.


Topics in this Post:



Leave a Comment

Your email address will not be published. Required fields are marked *